Skip to main content
    C

    Cartesian Therapeutics Inc. (RNAC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.08
    -0.27 (-4.25%)

    Market Cap: $193.69M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cartesian Therapeutics Inc. (RNAC) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Cartesian Therapeutics (RNAC) is expected to report earnings on Mar 8, 2027. In the quarter ended Sep 30, 2026, Cartesian Therapeutics reported EPS of -$0.38, above the -$1.02 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    57%(23/40)
    Avg Surprise
    +17.38%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 8, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.95
    Range-$1.18 - -$0.41
    9 analysts
    Revenue Consensus
    $348.50K
    RangeN/A
    9 analysts
    Reports Apr 28, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.86
    Range-$1.09 - -$0.42
    6 analysts
    EPS Revisions
    2
    1
    30d
    EPS Estimate DriftChange to current
    90d ago-$1.05+18.2%
    60d ago-$1.05+18.2%
    30d ago-$1.05+18.2%
    7d ago-$1.05+18.2%
    Current-$0.86
    Revenue Consensus
    $41.67K
    RangeN/A
    6 analysts

    Next Report

    RNAC has an expected report date of Mar 8, 2027.

    Earnings History

    Of the 40 quarters below that had an estimate, RNAC beat 23, missed 16 and matched 1. The widest gap in the table came in the quarter ended Jun 30, 2024, when EPS landed 811.11% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.38-$1.02N/A+62.75%BeatN/A10 up, 1 downNov 5, 2026N/A
    Jun 30, 2026$0.46-$0.83N/A+155.42%Beat-8.0%11 up, 0 downAug 6, 2026N/A
    Mar 31, 2026-$0.95-$0.70-$0.70 - -$0.70-35.71%MissN/A10 up, 0 downApr 30, 2026$78000
    Dec 31, 2025-$2.71-$0.79-$0.79 - -$0.79-242.59%MissN/A1N/AMar 9, 2026$947000
    Sep 30, 2025-$0.73-$0.63-$0.63 - -$0.63-15.87%MissN/A1N/ANov 6, 2025$452000
    Jun 30, 2025$0.50-$0.76N/A+165.79%Beat-21.9%10 up, 0 downAug 7, 2025$298000
    Mar 31, 2025-$0.65-$0.71N/A+8.45%BeatN/AN/A0 up, 0 downMay 8, 2025$1.10M
    Dec 31, 2024-$0.59-$0.83-$1.05 - -$0.61+28.12%BeatN/A52 up, 2 downMar 20, 2025N/A
    Sep 30, 2024-$0.42-$0.55-$0.97 - -$0.55+23.64%BeatN/A50 up, 0 downNov 7, 2024$387000
    Jun 30, 2024$0.64-$0.09N/A+811.11%BeatN/A60 up, 0 downAug 8, 2024$33.45M
    Mar 31, 2024-$0.80-$1.42-$1.50 - -$0.27+43.66%BeatN/A41 up, 0 downMay 8, 2024$5.84M
    Dec 31, 2023-$0.07-$0.04-$0.05 - -$0.02-75.00%Miss-275.0%20 up, 0 downMar 7, 2024$8.27M
    Sep 30, 2023-$0.06-$0.06-$0.10 - $0.040.00%In lineN/A60 up, 0 downNov 13, 2023$6.55M
    Jun 30, 2023-$0.07-$0.08-$0.12 - $0.03+12.50%Beat-216.7%60 up, 0 downAug 17, 2023$5.25M
    Mar 31, 2023-$0.14-$0.09-$0.14 - -$0.01-55.56%Miss-160.9%70 up, 0 downMay 4, 2023$5.94M
    Dec 31, 2022$0.04-$0.07-$0.14 - -$0.03+157.14%Beat+33.3%71 up, 0 downMar 30, 2023$16.80M
    Sep 30, 2022-$0.05-$0.01-$0.09 - $0.12-400.00%MissN/A70 up, 0 downDec 29, 2022$20.71M
    Jun 30, 2022$0.06-$0.08N/A+175.00%Beat+50.0%N/A1 up, 0 downSep 28, 2022$39.27M
    Mar 31, 2022$0.23-$0.11-$0.21 - -$0.07+309.09%BeatN/A60 up, 0 downJun 28, 2022$34.00M
    Dec 31, 2021$0.03-$0.07-$0.14 - -$0.02+142.86%BeatN/A7N/AMar 29, 2022$29.94M
    Sep 30, 2021-$0.16-$0.07-$0.18 - $0.00-128.57%MissN/A74 up, 0 downDec 29, 2021$24.43M
    Jun 30, 2021$0.04-$0.12-$0.19 - -$0.06+133.33%BeatN/A7N/ASep 28, 2021$19.66M
    Mar 31, 2021-$0.22-$0.12-$0.16 - -$0.08-83.33%MissN/A5N/AJun 28, 2021$11.05M
    Dec 31, 2020-$0.14-$0.12-$0.18 - -$0.07-16.67%MissN/A6N/AMar 29, 2021$11.95M
    Sep 30, 2020-$0.09$0.06-$0.15 - $0.65-250.00%MissN/A7N/ANov 5, 2020$4.65M
    Jun 30, 2020-$0.25-$0.30-$6.61 - $17.72+16.75%BeatN/A8N/AAug 6, 2020N/A
    Mar 31, 2020-$0.21-$0.28-$0.41 - -$0.18+25.00%BeatN/A8N/AMay 7, 2020N/A
    Dec 31, 2019-$0.30-$0.21-$0.28 - -$0.11-42.86%MissN/A7N/AMar 12, 2020$6.65M
    Sep 30, 2019-$0.26-$0.33-$0.37 - -$0.28+21.21%BeatN/A5N/ANov 8, 2019N/A
    Jun 30, 2019-$0.37-$0.30-$0.41 - -$0.25-23.33%MissN/A5N/AAug 8, 2019$13000
    Mar 31, 2019-$0.31-$0.35-$0.37 - -$0.31+11.43%BeatN/A5N/AMay 9, 2019$10000
    Dec 31, 2018-$0.65-$0.70-$0.76 - -$0.54+7.14%BeatN/A5N/AMar 31, 2019$903000
    Sep 30, 2018-$0.71-$0.75-$0.87 - -$0.49+5.33%BeatN/A6N/ANov 8, 2018N/A
    Jun 30, 2018-$0.84-$0.68-$0.78 - -$0.45-23.53%MissN/A5N/AAug 8, 2018N/A
    Mar 31, 2018-$0.71-$0.54-$0.72 - -$0.35-31.48%MissN/A4N/AMay 9, 2018N/A
    Dec 31, 2017-$0.88-$0.56-$1.12 - $0.00-57.14%MissN/A4N/AMar 31, 2018$17000
    Sep 30, 2017-$0.63-$0.87N/A+27.59%BeatN/AN/AN/ANov 7, 2017$27000
    Jun 30, 2017-$0.85-$0.90N/A+5.56%BeatN/AN/AN/AAug 11, 2017$26000
    Mar 31, 2017-$0.82-$1.28N/A+35.94%BeatN/AN/AN/AMay 11, 2017$137000
    Dec 31, 2016-$0.77-$0.25N/A-208.00%MissN/AN/AN/AMar 31, 2017$2.93M
    Last 40 quarters

    Estimates made before a stock split are shown on the same share basis as the reported EPS.

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$3.59, after -$1.17 the year before. It was -$3.95 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$3.59N/A
    Dec 31, 2024-$1.17N/A
    Dec 31, 2023-$0.34-221.4%
    Dec 31, 2022$0.28N/A
    Dec 31, 2021-$0.31N/A
    Dec 31, 2020-$0.69N/A
    Dec 31, 2019-$1.24N/A
    Dec 31, 2018-$2.91N/A
    Dec 31, 2017-$3.18N/A
    Dec 31, 2016-$3.95N/A

    Frequently Asked Questions About RNAC

    When is Cartesian Therapeutics's next earnings date?

    Cartesian Therapeutics's next earnings report is expected for Mar 8, 2027.

    Did RNAC beat earnings estimates last quarter?

    Yes. Cartesian Therapeutics reported EPS of -$0.38 for the quarter ended Sep 30, 2026, above the -$1.02 estimate, a 62.75% surprise.

    What EPS do analysts expect from RNAC next quarter?

    The consensus EPS estimate for Cartesian Therapeutics for the quarter ending Dec 31, 2026 is -$0.95 from 9 analysts, with estimates from -$1.18 to -$0.41.

    How often does RNAC beat earnings estimates?

    Cartesian Therapeutics beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +15.79%.